Transaction Date | Company Name | Insider Name (Title) | Activity | Stock | Acquired or Disposed | Shares | Price range | Amount |
---|---|---|---|---|---|---|---|---|
2024-11-06 | AMICUS THERAPEUTICS, INC. | Campbell Bradley L
(President and CEO) |
S | Common Stock | D | 7901 | $12.50 - $12.50 | $98,800 |
2024-11-06 | AMICUS THERAPEUTICS, INC. | Campbell Bradley L
(President and CEO) |
M | Common Stock | A | 7901 | $12.28 - $12.28 | $97,024 |
2024-11-01 | AMICUS THERAPEUTICS, INC. | Campbell Bradley L
(President and CEO) |
S | Common Stock | D | 7500 | $11.46 - $11.46 | $85,959 |
2024-11-01 | AMICUS THERAPEUTICS, INC. | Campbell Bradley L
(President and CEO) |
M | Common Stock | A | 7500 | $8.61 - $8.61 | $64,574 |
2024-10-01 | AMICUS THERAPEUTICS, INC. | Campbell Bradley L
(President and CEO) |
S | Common Stock | D | 7500 | $10.60 - $10.60 | $79,492 |
2024-10-01 | AMICUS THERAPEUTICS, INC. | Campbell Bradley L
(President and CEO) |
M | Common Stock | A | 7500 | $8.61 - $8.61 | $64,574 |
2024-08-01 | AMICUS THERAPEUTICS, INC. | Campbell Bradley L
(President and CEO) |
S | Common Stock | D | 7500 | $10.34 - $10.34 | $77,518 |
2024-08-01 | AMICUS THERAPEUTICS, INC. | Campbell Bradley L
(President and CEO) |
M | Common Stock | A | 7500 | $8.61 - $8.61 | $64,574 |
2024-07-05 | AMICUS THERAPEUTICS, INC. | Campbell Bradley L
(President and CEO) |
S | Common Stock | D | 6100 | $10.00 - $10.00 | $61,029 |
2024-07-05 | AMICUS THERAPEUTICS, INC. | Campbell Bradley L
(President and CEO) |
M | Common Stock | A | 6100 | $8.61 - $8.61 | $52,521 |
2024-07-01 | AMICUS THERAPEUTICS, INC. | Campbell Bradley L
(President and CEO) |
S | Common Stock | D | 1400 | $10.00 - $10.00 | $14,002 |
2024-07-01 | AMICUS THERAPEUTICS, INC. | Campbell Bradley L
(President and CEO) |
M | Common Stock | A | 1400 | $8.61 - $8.61 | $12,054 |
2024-06-06 | AMICUS THERAPEUTICS, INC. | WHITMAN BURKE W
(Director) |
A | Common Stock | A | 11847 | $0.00 - $0.00 | $0 |
2024-06-06 | AMICUS THERAPEUTICS, INC. | WHEELER CRAIG A
(Director) |
A | Common Stock | A | 11847 | $0.00 - $0.00 | $0 |
2024-06-06 | AMICUS THERAPEUTICS, INC. | ROBERTS EIRY
(Director) |
A | Common Stock | A | 11847 | $0.00 - $0.00 | $0 |
2024-06-06 | AMICUS THERAPEUTICS, INC. | Bleil Lynn Dorsey
(Director) |
A | Common Stock | A | 11847 | $0.00 - $0.00 | $0 |
2024-06-06 | AMICUS THERAPEUTICS, INC. | Kelly Michael Aaron
(Director) |
A | Common Stock | A | 11847 | $0.00 - $0.00 | $0 |
2024-06-06 | AMICUS THERAPEUTICS, INC. | SBLENDORIO GLENN
(Director) |
A | Common Stock | A | 11847 | $0.00 - $0.00 | $0 |
2024-06-06 | AMICUS THERAPEUTICS, INC. | RAAB MICHAEL
(Director) |
A | Common Stock | A | 11847 | $0.00 - $0.00 | $0 |
2024-06-06 | AMICUS THERAPEUTICS, INC. | MCGLYNN MARGARET G
(Director) |
A | Common Stock | A | 11847 | $0.00 - $0.00 | $0 |
2024-06-03 | AMICUS THERAPEUTICS, INC. | Campbell Bradley L
(President and CEO) |
S | Common Stock | D | 7500 | $10.00 - $10.00 | $75,000 |
2024-06-03 | AMICUS THERAPEUTICS, INC. | Campbell Bradley L
(President and CEO) |
M | Common Stock | A | 7500 | $8.61 - $8.61 | $64,574 |
A | Grant, award or other acquisition |
C | Conversion of Derivative or Security |
D | Disposition to the issuer of issuer equity securities |
E | Expiration of short derivative position |
F | Payment of exercise price or tax liability |
G | Bona fide Gift |
H | Expiration (or cancellation) of long derivative position with value received |
I | Discretionary Transaction |
J | Other acquisition or disposition |
K | Transaction in equity swap or instrument with similar characteristics |
L | Small Acquisition |
M | Exercise or conversion of derivative security |
O | Exercise of out-of-the-money derivative security |
P | Open Market Purchase |
S | Open Market Sale |
U | Disposition pursuant to a tender of shares in a change of control transaction |
V | Transaction Voluntarily Reported |
X | Exercise of in-the-money or at-the-money derivative security |
Z | Deposit into or withdrawal from voting trust |